Assurant Inc. 5.25% Subordinated Notes due 2061 (AIZN)

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look first at the business behind the paper. The filed figures show Assurant growing steadily: FY2023 revenue $11.1B, net income $642.5M, diluted EPS $11.95; FY2024 revenue $11.9B, net income $760.2M, diluted EPS $14.46; FY2025 revenue $12.8B, net income $872.7M, diluted EPS $16.93. In fiscal Q2 2026, revenue was $3.5B, net income $298.6M and diluted EPS $5.95, up from fiscal Q2 2025's $3.2B, $235.3M and $4.56. That is a respectable earnings record, and FairStock's computed Lynch category is STALWART, citing 14.6% annual profit growth and 6.0% revenue growth over five years. But this security is not the common stock; it is a 5.25% subordinated note due 2061. At the 2026-10-16 close of $17.15, it is near its 52-week low of $16.91 and below the $21.97 high. I cannot run a Graham bargain test because the provided P/E, P/B, ROE, ROCE and D/E figures are N/A, and for a note the relevant tests are coupon coverage, asset protection, credit spread and yield to maturity—none supplied. The earnings trend is a point in favor, but it does not by itself tell me how safe the subordinated claim is. I would want debt levels, interest coverage, and the note's call or redemption terms before judging value. The business looks steady; the note's price looks weak, but cheapness is unproven.

In plain English: Assurant is a financial services company. The security being analyzed is a long-term company note that pays 5.25% and matures in 2061, not common stock. Filed results show revenue and profit growing, but the $17.15 price near the low end of its 52-week range cannot be called cheap or expensive from the data given because the return it pays and how safe it is are not provided.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-16 close · note generated 2026-10-20 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer